Episode Details
Back to Episodes
Pharmaceutical Executive Daily: Nine European Drugmakers Note Concern Over Region's Pharma Investments
Published 1 month, 3 weeks ago
Description
Nine major European drugmakers warn the region risks losing pharma investment, Novartis licenses a preclinical radioligand therapy asset from BoomRay Pharmaceuticals, and Rafaat Rahmani argues that the costliest competitive intelligence failure is missing the moment a strategic assumption goes wrong.